Chronic Fatigue Syndrome News and Research

Latest Chronic Fatigue Syndrome News and Research

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Hemispherx amends Ampligen agreement with GP Pharm to include Mexico

Hemispherx amends Ampligen agreement with GP Pharm to include Mexico

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

Hemispherx announces publication of Ampligen Phase III data in Journal of Applied Research

Hemispherx announces publication of Ampligen Phase III data in Journal of Applied Research

Hemispherx Biopharma awarded grant for Ampligen, Alferon development programs

Hemispherx Biopharma awarded grant for Ampligen, Alferon development programs

Chronic fatigue syndrome associated with maladaptive personality features and personality disorders

Chronic fatigue syndrome associated with maladaptive personality features and personality disorders

New evidence supports possible link between XMRV and prostate cancer

New evidence supports possible link between XMRV and prostate cancer

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

Hemispherx Biopharma to present clinical data on XMRV retrovirus at International Workshop

Study finds cognitive behaviour therapy safe for chronic fatigue syndrome

Study finds cognitive behaviour therapy safe for chronic fatigue syndrome

Researchers find gene sequences of MLV in chronic fatigue syndrome patients' blood samples

Researchers find gene sequences of MLV in chronic fatigue syndrome patients' blood samples

NCF announces formal disease model for Chronic Fatigue Syndrome

NCF announces formal disease model for Chronic Fatigue Syndrome

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Deconstruction of biomedical research on pain will improve diagnosis, treatment of chronic pain sufferers

Deconstruction of biomedical research on pain will improve diagnosis, treatment of chronic pain sufferers

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Investment report on Hemispherx BioPharma

Investment report on Hemispherx BioPharma

AIDS specialist leaves Calif. practice, citing rising costs

AIDS specialist leaves Calif. practice, citing rising costs

CFIDS Association applauds AABB for responding to questions about safety of general blood supply

CFIDS Association applauds AABB for responding to questions about safety of general blood supply

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

Corvalen M introduced for treatment of fibromyalgia symptoms

Corvalen M introduced for treatment of fibromyalgia symptoms

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV